Risk factor modification through nonpharmacological interventions in patients with coronary heart disease

被引:31
作者
Sebregts, EHWJ
Falger, PRJ
Bär, FWHM
机构
[1] Maastricht Univ, Dept Med Clin & Expt Psychol, NL-6200 MD Maastricht, Netherlands
[2] Univ Hosp Maastricht, Dept Cardiol, Maastricht, Netherlands
关键词
coronary heart disease; nonpharmacological interventions; risk factor modification; secondary prevention; review; controlled clinical trials;
D O I
10.1016/S0022-3999(99)00113-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Coronary heart disease (CHD) is still the main cause of death in developed countries. Because of improved treatment, many patients survive the acute phase of a myocardial infarction, which makes secondary prevention of CHD of major importance. Most risk factors responsible for the development and progression of CI-ID are associated with behavior. Therefore, interventions aimed at behavior change may contribute to risk factor modification and secondary prevention of CL-ID. The effects of separate risk factor modification efforts by means of randomized, controlled clinical trials of nonpharmacological interventions in patients suffering From CHD are reviewed. Interventions aimed at healthy lifestyles may stimulate smoking cessation rates, reduce elevated serum total and low-density lipoprotein (LDL)-cholesterol concentrations, and favorably modify type A behavior in CHD patients. Moreover, reduction of coronary atherosclerosis has been reported after intensive lifestyle and exercise interventions, whereas exercise and type A interventions may also lead to reduced Ct-ID morbidity and mortality. As for hypertension and obesity, studies aimed at secondary prevention are lacking. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:425 / 441
页数:17
相关论文
共 102 条